Cancer – Page 18 – Patient Worthy

stevepb / Pixabay

An Experimental Drug Combination Treatment for Certain Bowel Cancers Has Been Granted Breakthrough Therapy Designation

Post author:Anna Hewitt
Post published:August 16, 2018
Post category:Cancer

The US FDA has awarded Breakthrough Therapy Designation to encorafenib (braftoviTM) combined with binimetinib (mektovi®) and cetuximab for use as an investigational (not FDA-approved) treatment of BRAFV600E–mutant metastatic colorectal cancer.…

The FDA Have Granted Priority Review to Elzonris for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm

Post author:Anna Hewitt
Post published:August 15, 2018
Post category:Acute Myeloid Leukemia Blastic plasmacytoid dendritic cell neoplasm

A Biologics License Application for ElzonrisTM (also known as tagraxofusp and SL-401) for the treatment of blastic plasmacytoid dendritic cell neoplasm has been accepted for filing by the United States FDA.…

felixioncool / Pixabay

A Combination of Arsenic with Another Drug May Have the Potential to Treat Cancer, Researchers Say

Post author:Anna Hewitt
Post published:August 14, 2018
Post category:Cancer

A research team led by scientists from the Beth Israel Deaconess Medical Center (BIDMC) have found that arsenic, in combination with the drug all-trans retinoic acid (ATRA), may have the potential…

https://pixabay.com/en/star-clusters-rosette-nebula-star-67616/

Doctor’s Memoir ‘Cancerland’ Brings a Human Side to Cancer Study

Post author:Octavia Walker
Post published:August 8, 2018
Post category:Brain Cancer

Dr. David Scadden is a hematologist, oncologist, and Harvard medical school professor. He is also the author of a memoir for a book recalling his early medical schooling and career.…

Watch: The View Welcomes Girl Fighting Glioblastoma to Show

Post author:Jean Martell
Post published:July 26, 2018
Post category:Glioblastoma Rare Disease

We here at Patient Worthy shine a spotlight on rare diseases, but these disorders often get overlooked by much of the media. So anytime a rare disease is discussed out…

Source: Pixabay.com

Zap! New Genetic Therapy Technique Electrocutes Cancer Cells into Submission

Post author:Dawn Scott
Post published:July 26, 2018
Post category:Leukemia Non-Hodgkin's lymphoma- during pregnancy Rare Disease

In a Washington Post article by Ben Guarino, new cancer treatments lasso the power of naturally occurring immune cells in the body. Researchers are looking into ways modify them to…

fancycrave1 / Pixabay

Mother-Son Team Raises Awareness for Osteosarcoma at Swimming Event

Post author:Samuel Sachs
Post published:July 26, 2018
Post category:Osteosarcoma

Filipa Vance, a woman who was diagnosed with osteosarcoma when she was 15, now celebrates 30 years of living post-diagnosis. Filipa is now cancer-free, but lives with many of the…

valelopardo / Pixabay

A Patient With Waldenström Macroglobulinemia has Shown a Large Reduction in Overall Tumour Volume While Taking Part in a Clinical Trial

Post author:Anna Hewitt
Post published:July 19, 2018
Post category:Waldenstrom Macroglobulinemia

A patient with Waldenström Macroglobulinemia taking part in a clinical trial of the experimental drug CLR 131 for the treatment of B-cell hematologic cancers is reported to have achieved a…

Source: Pixabay

Supplemental New Drug Application Submitted For Potential Acute Myeloid Leukemia Treatment

Post author:James Moore
Post published:July 19, 2018
Post category:Acute Myeloid Leukemia Rare Disease

According to a story from PR Newswire, the biopharmaceutical company AbbVie has recently announced that it has sent a supplemental New Drug Application to the FDA for its product venetoclax,…

Free-Photos / Pixabay

An Application to Extend the Use of Rubraca for Treating Ovarian Cancer has Been Submitted to the European Medicines Agency

Post author:Anna Hewitt
Post published:July 19, 2018
Post category:Ovarian Cancer

Clovis Oncology, Inc. has announced that they have submitted an application to the European Medicines Agency (EMA). The application is to extend the drug Rubraca’s®(rucaparib) marketing authorisation to include maintenance…

allinonemovie / Pixabay

Natural Killer Cells May Be Useful For Predicting How Patients Respond to Certain Immunotherapies, According to Recent Research

Post author:Anna Hewitt
Post published:July 17, 2018
Post category:Cancer

A recent study, published here in the journal Nature Medicine and used as the source for this article, has found that certain kinds of cells may be useful for predicting…

kkolosov / Pixabay

Encouraging Results Have Been Announced From a Trial of an Investigational Treatment For BPDCN

Post author:Anna Hewitt
Post published:July 12, 2018
Post category:Blastic plasmacytoid dendritic cell neoplasm

Results from research into an experimental therapy called SL-401 for the treatment of patients with blastic plasmacytoid dendritic cell neoplasm have been shared at the Congress of the European Haematology…

Pexels / Pixabay

After Battling Cancer, Survivors Should Keep an Eye Out for Endocrine Disease, According to One Study

Post author:Anna Hewitt
Post published:July 10, 2018
Post category:Cancer

A recently published study found that, out of the people studied, young cancer survivors were more likely to develop endocrine diseases than people who had no history of cancer. The…

Source: Pixabay

Non-Hodgkin’s Lymphoma Case Becomes First Against Roundup and Monsanto

Post author:Samuel Sachs
Post published:July 6, 2018
Post category:Rare Disease

Dewayne Johnson used to work as a school groundskeeper. Now, some days, he can’t manage to speak as a result of the cancer he lives with. Now, despite professional expectations…

Source: Pixabay

The Orphan Drug Designation for the Drug Dovitinib Has Been Transferred to a New Company

Post author:Anna Hewitt
Post published:July 6, 2018
Post category:Adenoid Cystic Carcinoma

The Orphan Drug Designation awarded to the drug dovitinib for treating adenoid cystic carcinoma has been transferred from Novartis to Oncology Venture. The full article can be found here, at…

Join the Rare 13 Campaign for Gastrointestinal Stromal Tumors Awareness

Post author:Jean Martell
Post published:July 5, 2018
Post category:Gastrointestinal Stromal Tumors Rare Disease

July 13th is Gastrointestinal Stromal Tumors Awareness Day! And that "13" has extra relevance. 5,000 Americans are diagnosed with Gastrointestinal Stromal Tumors (GIST) each year. That’s 13 people diagnosed each day.…

Source: Pixabay

Sweet-P: One Possible New Secret Ingredient Against Glioblastoma

Post author:Samuel Sachs
Post published:July 5, 2018
Post category:Brain Cancer Glioblastoma

According to a report from the University of Toledo, researchers developed a new molecule that could stop cancer in its tracks. The molecule, known as Sweet-P, works by targeting a…

Source: Pixabay

Could Flying Increase Risk of Thyroid Cancer? A New Study Says “Yes” for Flight Crew

Post author:Samuel Sachs
Post published:July 4, 2018
Post category:Thyroid Cancer

According to a report by The Herald Scotland Online, a landmark study recently revealed that flight crews are exposed to greater risk than the average citizen. Surprisingly, the results have…

Source: Pixabay

Is Chemotherapy Here To Stay?

Post author:Samuel Sachs
Post published:July 2, 2018
Post category:Breast Cancer Cancer Ovarian Cancer

According to a report by NBC news, despite seemingly endless advancements in cancer treatment, many experts agree that chemotherapy is still a powerful and valid tool. In fact, many see…

Free-Photos / Pixabay

Orphan Drug Designation Has Been Awarded to an Investigational Treatment for Burkitt Lymphoma

Post author:Anna Hewitt
Post published:July 1, 2018
Post category:Burkitt's lymphoma

The US FDA has awarded Orphan Drug Designation to the experimental drug CPI-613, for the treatment of Burkitt lymphoma. The full article can be read here, at Globe Newswire. About…

OpenClipart-Vectors / Pixabay

The Australian Government Will Give $33 Million to Researchers Studying Rare Cancers and Diseases

Post author:Anna Hewitt
Post published:July 1, 2018
Post category:Rare Disease

The Australian government will give $33 million to researchers to study rare cancers and rare diseases. The original article can be read here, at the Department of Health’s website. Background…

How Rapid Autopsy Could Change What We Know About Rare Disease

Post author:Samuel Sachs
Post published:June 27, 2018
Post category:Multiple Sclerosis Pancreatic Cancer Rare Disease

Understanding diseases and the mechanisms behind them is a crucial step towards developing treatment. Many times, however, it's difficult to accomplish this due to the rarity of a condition, or…

stevepb / Pixabay

Results From Trials of Jakavi For Treating Polycythemia Vera and Myelofibrosis Have Been Released

Post author:Anna Hewitt
Post published:June 26, 2018
Post category:Cancer Polycythemia vera primary myelofibrosis

The drug Jakavi (ruxolitinib) is being investigated as a possible treatment for polycythemia vera (PV) and myelofibrosis. Results from studies into this were presented by Novartis at the 23rd Congress of…

PublicDomainPictures / Pixabay

Researchers Recommend Genetic Testing For Some Medulloblastoma Sub-Groups

Post author:Anna Hewitt
Post published:June 26, 2018
Post category:Medulloblastoma

A study that looked into what genetic factors influence medulloblastoma development has been published in Lancet Oncology. In it, researchers outline several genes they believe are linked to tumour formation…

$The FDA has approved Keytruda For the Treatment of Refractory Primary Mediastinal Large B-cell Lymphoma$

Source: Pixabay

The FDA has approved Keytruda For the Treatment of Refractory Primary Mediastinal Large B-cell Lymphoma

Post author:Anna Hewitt
Post published:June 20, 2018
Post category:Anaplastic large cell lymphoma Cancer

The U.S. Food and Drug Administration (FDA) has approved the medicine Keytruda for the treatment of adult and pediatric patients with refractory primary mediastinal large B-cell lymphoma, that have relapsed…

An Experimental Drug Combination Treatment for Certain Bowel Cancers Has Been Granted Breakthrough Therapy Designation

The FDA Have Granted Priority Review to Elzonris for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm

A Combination of Arsenic with Another Drug May Have the Potential to Treat Cancer, Researchers Say

Doctor’s Memoir ‘Cancerland’ Brings a Human Side to Cancer Study

Watch: The View Welcomes Girl Fighting Glioblastoma to Show

Zap! New Genetic Therapy Technique Electrocutes Cancer Cells into Submission

Mother-Son Team Raises Awareness for Osteosarcoma at Swimming Event

A Patient With Waldenström Macroglobulinemia has Shown a Large Reduction in Overall Tumour Volume While Taking Part in a Clinical Trial

Supplemental New Drug Application Submitted For Potential Acute Myeloid Leukemia Treatment

An Application to Extend the Use of Rubraca for Treating Ovarian Cancer has Been Submitted to the European Medicines Agency

Natural Killer Cells May Be Useful For Predicting How Patients Respond to Certain Immunotherapies, According to Recent Research

Encouraging Results Have Been Announced From a Trial of an Investigational Treatment For BPDCN

After Battling Cancer, Survivors Should Keep an Eye Out for Endocrine Disease, According to One Study

Non-Hodgkin’s Lymphoma Case Becomes First Against Roundup and Monsanto

The Orphan Drug Designation for the Drug Dovitinib Has Been Transferred to a New Company

Join the Rare 13 Campaign for Gastrointestinal Stromal Tumors Awareness

Sweet-P: One Possible New Secret Ingredient Against Glioblastoma

Could Flying Increase Risk of Thyroid Cancer? A New Study Says “Yes” for Flight Crew

Is Chemotherapy Here To Stay?

Orphan Drug Designation Has Been Awarded to an Investigational Treatment for Burkitt Lymphoma

The Australian Government Will Give $33 Million to Researchers Studying Rare Cancers and Diseases

How Rapid Autopsy Could Change What We Know About Rare Disease

Results From Trials of Jakavi For Treating Polycythemia Vera and Myelofibrosis Have Been Released

Researchers Recommend Genetic Testing For Some Medulloblastoma Sub-Groups

The FDA has approved Keytruda For the Treatment of Refractory Primary Mediastinal Large B-cell Lymphoma

Let’s Work Together!

Keep Up to Date

Learn More